Society for Immunotherapy of Cancer
The Society for Immunotherapy of Cancer, previously known as the International Society for Biological Therapy of Cancer, is a professional society of scientists, academicians, researchers, clinicians, government representatives, and industry leaders from around the world dedicated to improving outcomes in patients with cancer by advancing the science and application of cancer immunotherapy. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Society for Immunotherapy of Cancer, United States, covering academic research published from 2003 to 2022. Read More.
Open Access Percentage
74%
Total
Publications
61
Total Open
Publications
45
Total
Citations
2.1K
Open Access
Percentage
74%
Total
Publications
61
Total Open
Publications
45
Total
Citations
2.1K
Breakdown
Publisher Open
2%
Both
69%
Other Platform Open
3%
Closed
26%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 91%
39
Hybrid 0%
0
No Guarantees 9%
4
Other Platform Open
Domain 95%
42
Institution 16%
7
Other Internet 7%
3
Preprint 0%
0
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 42 |
Europe PMC | Domain | 35 |
University of Pittsburgh - D-Scholarship@Pitt | Institution | 4 |
University of California - eScholarship University of California | Institution | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - Inserm | Institution | 2 |
Vrije Universiteit Amsterdam - VU Research Portal | Institution | 1 |
Université de Lausanne - SERVAL | Institution | 1 |
University of Toronto - TSpace | Institution | 1 |
University of Michigan - Deep Blue | Institution | 1 |
University of Melbourne - Minerva Access | Institution | 1 |